Knight Cancer Translational Oncology Program

Research output

Research output per year 1987 2017 2018 2019 2020 2021 2022 2023 2024

• 1436 Article
• 205 Review article
• 105 Letter
• 100 Comment/debate
• 74 More
  • 37 Chapter
  • 26 Editorial
  • 8 Short survey
  • 2 Conference contribution
  • 1 Foreword/postscript

Research output per year

Research output per year

Search results

• 2024

  A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

  Shree, T., Haebe, S., Czerwinski, D. K., Eckhert, E., Day, G., Sathe, A., Grimes, S., Frank, M. J., Maeda, L. S., Alizadeh, A. A., Advani, R., Hoppe, R. T., Long, S. R., Martin, B., Ozawa, M. G., Khodadoust, M. S., Ji, H. P. & Levy, R., Jan 9 2024, In: Blood Advances. 8, 1, p. 130-142 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Single-Cell Analysis 100%
  • Lymphoma 61%
  • Vaccination 59%
  • Clinical Trials 48%
  • Neoplasms 24%

• A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative

  UPGRADE, Mar 2024, In: British Journal of Dermatology. 190, 3, p. 392-401 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Pyoderma Gangrenosum 100%
  • Consensus 67%
  • Politics 17%
  • Clinical Trials 13%
  • Exercise 13%
  1 Scopus citations

• Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia

  Kohs, T. C. L., Vu, H. H., Jordan, K. R., Parra-Izquierdo, I., Hinds, M. T., Shatzel, J. J., Kievit, P., Morgan, T. K., Yunga, S. T., Ngo, T. T. M., Aslan, J. E., Wallisch, M., Lorentz, C. U., Tucker, E. I., Gailani, D., Lindner, J. R., Puy, C. & McCarty, O. J. T., Jan 2024, In: Research and Practice in Thrombosis and Haemostasis. 8, 1, 102276.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Platelet Activation 100%
  • Hyperlipidemias 91%
  • Primates 84%
  • Inflammation 53%
  • Blood Platelets 30%
  1 Scopus citations

• Acute and definitive management of oropharyngeal hemorrhage in patients with squamous cell carcinoma of the oropharynx

  Araujo, A. V., Wax, M. K., Clayburgh, D. R., Andersen, P. E., Chandra, R. & Li, R. J., Apr 2024, In: Head and Neck. 46, 4, p. 896-904 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Oropharynx 100%
  • Squamous Cell Carcinoma 68%
  • Hemorrhage 53%
  • Chemoradiotherapy 35%
  • External Carotid Artery 21%

• An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum

  Haddadin, O. M., Ortega-Loayza, A. G., Marzano, A. V., Davis, M. D. P., Dini, V., Dissemond, J., Hampton, P. J., Navarini, A. A., Shavit, E., Tada, Y., Yamamoto, T. & Alavi, A. A., Apr 2024, In: Archives of Dermatological Research. 316, 3, 89.

  Research output: Contribution to journal › Letter › peer-review

• Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN

  Shen, J., Chowdhury, S., Agarwal, N., Karsh, L. I., Oudard, S., Gartrell, B. A., Feyerabend, S., Saad, F., Pieczonka, C. M., Chi, K. N., Brookman-May, S. D., Rooney, B., Bhaumik, A., McCarthy, S. A., Bevans, K. B., Mundle, S. D., Small, E. J., Smith, M. R. & Graff, J. N., Jan 31 2024, In: British Journal of Cancer. 130, 1, p. 73-81 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • apalutamide 100%
  • Prostatic Neoplasms 41%
  • Androgens 40%
  • Castration 38%
  • Clinical Studies 36%

• A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia

  Patel, S. P., Othus, M., Chae, Y. K., Dennis, M. J., Gordon, S., Mutch, D., Samlowski, W., Rusty Robinson, W. R., Sharon, E., Ryan, C., Lopez, G., Plets, M., Blanke, C. & Kurzrock, R., Jan 10 2024, In: Clinical Cancer Research. 30, 1, p. 33-38 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Gestational Trophoblastic Disease 100%
  • Progression-Free Survival 40%
  • Ipilimumab 37%
  • Nivolumab 36%
  • Neoplasms 22%

• A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation

  Bubalo, J. S., Radke, J. L., Bensch, K. G., Chen, A. I., Misra, S. & Maziarz, R. T., Mar 2024, In: Journal of Oncology Pharmacy Practice. 30, 2, p. 304-312 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • netupitant 100%
  • Palonosetron 85%
  • Cell Transplantation 56%
  • Nausea 46%
  • Vomiting 45%
  1 Scopus citations

• A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML

  Cai, S. F., Huang, Y., Lance, J. R., Mao, H. C., Dunbar, A. J., McNulty, S. N., Druley, T., Li, Y., Baer, M. R., Stock, W., Kovacsovics, T., Blum, W. G., Schiller, G. J., Olin, R. L., Foran, J. M., Litzow, M., Lin, T., Patel, P., Foster, M. C., Boyiadzis, M., & 18 othersCollins, R. H., Chervin, J., Shoben, A., Vergilio, J. A., Heerema, N. A., Rosenberg, L., Chen, T. L., Yocum, A. O., Druggan, F., Marcus, S., Stefanos, M., Druker, B. J., Mims, A. S., Borate, U., Burd, A., Byrd, J. C., Levine, R. L. & Stein, E. M., Jan 23 2024, In: Blood Advances. 8, 2, p. 429-440 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• A Survey of Microvascular Technique Preferences Among American Head Neck Society Members

  Philips, R., Best, K. A., Agarwal, A., Sagheer, H., Selman, Y., Sweeney, L., Wax, M., Krein, H., Heffelfinger, R., Luginbuhl, A. & Curry, J., Mar 2024, In: Laryngoscope. 134, 3, p. 1265-1277 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Head 100%
  • Surgeons 97%
  • Sutures 74%
  • Dissection 47%
  • Laryngoscopes 34%

• Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial (Nature Medicine, (2023), 29, 11, (2825-2834), 10.1038/s41591-023-02568-1)

  Galsky, M. D., Daneshmand, S., Izadmehr, S., Gonzalez-Kozlova, E., Chan, K. G., Lewis, S., Achkar, B. E., Dorff, T. B., Cetnar, J. P., Neil, B. O., D’Souza, A., Mamtani, R., Kyriakopoulos, C., Jun, T., Gogerly-Moragoda, M., Brody, R., Xie, H., Nie, K., Kelly, G., Horowitz, A., & 20 othersKinoshita, Y., Ellis, E., Nose, Y., Ioannou, G., Cabal, R., Del Valle, D. M., Haines, G. K., Wang, L., Mouw, K. W., Samstein, R. M., Mehrazin, R., Bhardwaj, N., Yu, M., Zhao, Q., Kim-Schulze, S., Sebra, R., Zhu, J., Gnjatic, S., Sfakianos, J. & Pal, S. K., 2024, (Accepted/In press) In: Nature medicine.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Can we truly define ‘Fitness’ for CAR-T therapy in large B cell lymphoma patients?

  Chen, A. I. & Maziarz, R. T., Feb 2024, In: Chinese Clinical Oncology. 13, 1, 15.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Clinician overconfidence in visual estimation of the posthepatectomy liver remnant volume: A proximal source of liver failure after major hepatic resection?

  Forton, C., Sandoval, V., Schwantes, I. R., Patel, R. K., Kolbeck, K., Dewey, E. N., Korngold, E. K. & Mayo, S. C., 2024, (Accepted/In press) In: Surgery (United States).

  Research output: Contribution to journal › Article › peer-review

• CML and the WHO: Why?

  Berman, E., Shah, N. P., Deninger, M., Altman, J. K., Amaya, M., Begna, K., Bhatia, R., Chan, O., Collins, R., Curtin, P., Deangelo, D. J., Drazer, M., Maness, L., Metheny, L., Mohan, S., Moore, J., Oehler, V., Pratz, K., Pusic, I., Rose, M., & 15 othersShomali, W., Smith, B. D., Styler, M., Sweet, K., Talpaz, M., Tanaka, T., Tantravahi, S., Tsai, S., Vaughn, J., Welborn, J., Yang, D., Mauro, M., Cortes, J., Radich, J. & Druker, B., Mar 20 2024, In: Journal of Clinical Oncology. 42, 9, p. 984-986 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Colorectal Disease and the Gut Microbiome: What a Surgeon Needs to Know

  Rahman, S., Lu, E., Patel, R. K., Tsikitis, V. & Martindale, R. G., 2024, (Accepted/In press) In: Surgical Clinics of North America.

  Research output: Contribution to journal › Review article › peer-review

• Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin

  Kartika, T., Mathews, R., Migneco, G., Bundy, T., Kaempf, A. J., Pfeffer, M., DeLoughery, T. G., Moore, K., Beardshear, R., Oetken, H. J., Case, J., Hinds, M. T., McCarty, O. J. T., Shatzel, J. J., Zonies, D. & Zakhary, B., Apr 2024, In: European Journal of Haematology. 112, 4, p. 566-576 11 p.

  Research output: Contribution to journal › Article › peer-review

  • bivalirudin 100%
  • Extracorporeal Membrane Oxygenation 79%
  • Heparin 61%
  • Hemorrhage 43%
  • Longevity 6%

• Comparison of da Vinci Single Port vs Si Systems for Transoral Robotic-Assisted Surgery A Review With Technical Insights

  Oberhelman, N., Bruening, J., Jackson, R. S., Van Abel, K. M., Sumer, B., Holsinger, F. C., Chan, J. Y. K., Gross, N. D., Clayburgh, D. R., Andersen, P. E. & Li, R. J., Feb 8 2024, In: JAMA Otolaryngology - Head and Neck Surgery. 150, 2, p. 165-171 7 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Scopus citations

• Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis

  McCully, B. H., Kozuma, K., Pommier, S. E. & Pommier, R. F., 2024, (Accepted/In press) In: Annals of surgical oncology.

  Research output: Contribution to journal › Article › peer-review

  • Octreotide 100%
  • Carcinoid Tumor 93%
  • Anesthesia 24%
  • Hormones 14%
  • Therapeutics 13%

• Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era

  Das, S., Luu, M., Terris, M., Klaassen, Z., Kane, C. J., Amling, C., Cooperberg, M., Rivera, L. G., Aronson, W., Freedland, S. J. & Daskivich, T. J., 2024, (Accepted/In press) In: Urologic Oncology: Seminars and Original Investigations.

  Research output: Contribution to journal › Article › peer-review

• Correction: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies (Archives of Dermatological Research, (2023), 315, 8, (2295-2302), 10.1007/s00403-023-02613-6)

  Dhillon, S., Duarte-Bateman, D., Fowler, G., Hagstrom, M. N. E., Lampley, N., Olivares, S., Fumero-Velázquez, M. S., Vu, K., Wayne, J. D., Gastman, B. R., Vetto, J. & Gerami, P., Jan 2024, In: Archives of Dermatological Research. 316, 1, 6.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Tumor Burden 100%
  • Publications 87%
  • Melanoma 87%

• CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial

  Solomon, S. R., Powell, B. L., Koprivnikar, J., Lai, C., Male, H., Michaelis, L. C., Newell, L. F., Sanford, D., Jenkins, J., Zelaya, A., Coppola, S., Faderl, S. & Walter, R. B., Mar 2024, In: Cancers. 16, 5, 915.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • CPX-351 100%
  • Hematologic Neoplasms 52%
  • Pharmacokinetics 39%
  • Safety 30%
  • Kidney 27%

• Deep Vein Thrombosis and Healing Outcomes in Patients With Pyoderma Gangrenosum

  Zhao, H., Sengupta, S. K., Sisley, J. M., Haddadin, O., Pfeifer, H. & Ortega-Loayza, A. G., 2024, (Accepted/In press) In: JAMA Dermatology.

  Research output: Contribution to journal › Article › peer-review

• DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations

  Innocenti, F., Mu, W., Qu, X., Ou, F. S., Kabbarah, O., Blanke, C. D., Venook, A. P., Lenz, H. J. & Rashid, N. U., Feb 1 2024, In: Journal of Clinical Oncology. 42, 4, p. 399-409 11 p.

  Research output: Contribution to journal › Article › peer-review

  • DNA Fingerprinting 100%
  • Standard of Care 77%
  • Colorectal Neoplasms 63%
  • Mutation 44%
  • Survival 15%
  1 Scopus citations

• Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from SEARCH

  Guerrios-Rivera, L., Janes, J. L., De Hoedt, A. M., Klaassen, Z., Terris, M. K., Cooperberg, M. R., Amling, C. L., Kane, C. J., Aronson, W. J., Fowke, J. H. & Freedland, S. J., Feb 2024, In: Cancer medicine. 13, 4, e7012.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Prostatectomy 100%
  • Hispanic Americans 93%
  • Prostatic Neoplasms 16%
  • Extranodal Extension 14%
  • Castration 11%

• Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

  Dreyling, M., Fowler, N. H., Dickinson, M., Martinez-Lopez, J., Kolstad, A., Butler, J., Ghosh, M., Popplewell, L., Chavez, J. C., Bachy, E., Kato, K., Harigae, H., Kersten, M. J., Andreadis, C., Riedell, P. A., Ho, P. J., Pérez-Simón, J. A., Chen, A. I., Nastoupil, L. J., von Tresckow, B., & 20 othersMaría Ferreri, A. J., Teshima, T., Patten, P. E. M., McGuirk, J. P., Petzer, A. L., Offner, F., Viardot, A., Zinzani, P. L., Malladi, R., Paule, I., Zia, A., Awasthi, R., Han, X., Germano, D., O'Donovan, D., Ramos, R., Maier, H. J., Masood, A., Thieblemont, C. & Schuster, S. J., 2024, (Accepted/In press) In: Blood.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group

  Kamal, K., Xia, E., Li, S. J., Alavi, A., Cogen, A. L., Firooz, A., Marzano, A. V., Kaffenberger, B. H., Sibbald, C., Fernandez, A. P., Callen, J. P., Dissemond, J., Gontijo, J. R. V., Shams, K., Gerbens, L. A., French, L. E., Gould, L. J., Bissonnette, R., Shaigany, S., Tolkachjov, S., & 4 othersYamamoto, T., Wei-Ting Huang, W., Ortega-Loayza, A. G. & Mostaghimi, A., 2024, (Accepted/In press) In: Journal of Investigative Dermatology.

  Research output: Contribution to journal › Article › peer-review

  • Pyoderma Gangrenosum 100%
  • Clinical Trials 46%
  • Delphi Technique 31%
  • Ulcer 21%
  • Drug Approval 15%

• Establishing a robust radioligand therapy program: A practical approach for North American centers

  Mittra, E. S., Wong, R. K. S., Winters, C., Brown, A., Murley, S. & Kennecke, H., Feb 2024, In: Cancer medicine. 13, 3, e6780.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Gastro-enteropancreatic neuroendocrine tumor 100%
  • Therapeutics 84%
  • Lymphoma 53%
  • Prostatic Neoplasms 51%
  • Neoplasms 20%

• Evaluation of Inclusion and Exclusion Criteria for Pyoderma Gangrenosum in Clinical Research: A Systematic Review

  Li, S. J., Xia, E., Drake, L., Erickson, K., Ortega-Loayza, A. G. & Mostaghimi, A., Feb 1 2024, In: Dermatology. 240, 1, p. 26-31 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pyoderma Gangrenosum 100%
  • Systematic Reviews 52%
  • Clinical Trials 13%
  • Dermatologists 5%
  • Consensus 4%

• Expert Commentary on Hepatic Artery Infusion Pump Chemotherapy for Colorectal Liver Metastases

  Mayo, S. C., Feb 1 2024, In: Diseases of the colon and rectum. 67, 2, p. 204-205 2 p.

  Research output: Contribution to journal › Article › peer-review

• Factor XI as a therapeutic target in neuroinflammatory disease

  Taskin, B., Kohs, T. C. L., Shatzel, J. J., Puy, C. & McCarty, O. J. T., Jan 1 2024, In: Current opinion in hematology. 31, 1, p. 32-38 7 p.

  Research output: Contribution to journal › Review article › peer-review

  • Factor XI 100%
  • Multiple Sclerosis 60%
  • Hashimoto's encephalitis 33%
  • Blood-Brain Barrier 33%
  • Thrombin 22%

• Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients with Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial

  Pfeffer, M. A., Kohs, T. C. L., Vu, H. H., Jordan, K. R., Wang, J. S. H., Lorentz, C. U., Tucker, E. I., Puy, C., Olson, S. R., Deloughery, T. G., Hinds, M. T., Keshari, R. S., Gailani, D., Lupu, F., McCarty, O. J. T. & Shatzel, J. J., Jan 1 2024, In: Arteriosclerosis, thrombosis, and vascular biology. 44, 1, p. 290-299 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Factor XI 100%
  • Catheters 53%
  • Thrombosis 52%
  • Clinical Trials 44%
  • Hemorrhage 26%
  1 Scopus citations

• From planned neck dissection to PET response to circulating tumour DNA: changes in post-treatment assessment of HPV-driven oropharyngeal cancer^†

  Post, C. M., Ohaegbulam, K. C. & Mitin, T., Mar 2024, In: Journal of Medical Radiation Sciences. 71, 1, p. 21-25 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Circulating Tumor DNA 100%
  • Oropharyngeal Neoplasms 92%
  • Neck Dissection 81%
  • DNA 21%
  • Squamous Cell Carcinoma 21%
  1 Scopus citations

• Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

  McCarthy, P. L., Attwood, K. M., Liu, X., Chen, G. L., Minderman, H., Alousi, A., Bashey, A., Lowsky, R., Miklos, D. B., Hansen, J., Westervelt, P., Yanik, G., Waller, E. K., Howard, A., Blazar, B. R., Wallace, P. K., Reshef, R., Horowitz, M. M., Maziarz, R. T., Levine, J. E., & 1 othersMohammadpour, H., Mar 2024, In: Bone marrow transplantation. 59, 3, p. 334-343 10 p.

  Research output: Contribution to journal › Article › peer-review

• Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective

  Maziarz, R. T., Gergis, U., Edwards, M. L., Song, Y., Liu, Q., Anderson, A., Signorovitch, J., Manghani, R., Simantov, R., Shin, H. & Sivaraman, S., Mar 12 2024, In: Blood Advances. 8, 5, p. 1200-1208 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Hepatic cytoreduction for lung and renal neuroendocrine tumor metastases

  Fowler, K., Li, J. & Pommier, R. F., 2024, (Accepted/In press) In: American journal of surgery.

  Research output: Contribution to journal › Article › peer-review

  • Neuroendocrine Tumors 100%
  • Neoplasm Metastasis 54%
  • Kidney 47%
  • Lung 47%
  • Liver 45%

• Hundreds of inconsistencies in the nomenclature of pyoderma gangrenosum: The need to harmonise terminology for phenotypes

  Zhao, H., Larson, C., Schepergerdes, B. J., Diefendorf, C. M., Ortega-Loayza, A. G. & Mostaghimi, A., Jan 2024, In: International Wound Journal. 21, 1, e14357.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Imaging of the hepatic arterial infusion pump: Primer for radiologists

  Bonde, A., Fung, A. W., Mayo, S. C., Li, P., Walker, B. S., Jaganathan, S., Mallak, N. & Korngold, E. K., Jan 2024, In: Clinical Imaging. 105, 110022.

  Research output: Contribution to journal › Review article › peer-review

  • Infusion Pumps 100%
  • Radiologists 70%
  • Liver 39%
  • Perfusion Imaging 11%
  • Cholangiocarcinoma 10%

• Immunological dynamic characteristics in acute myeloid leukemia predict the long-term outcomes and graft-versus host-disease occurrences post-transplantation

  Wang, W., Li, H., Guo, Y., Zhang, L., Jiang, W., Zheng, N., Peng, S., Guan, X., Fan, G. & Shen, L., Feb 2024, In: Clinical and Experimental Immunology. 215, 2, p. 148-159 12 p.

  Research output: Contribution to journal › Article › peer-review

• Liver stereotactic body radiation therapy without fiducial or retained ethiodized oil guidance warrants greater than 5 mm planning target volumes

  Breazeale, A., Rahmani, R., Gallagher, K. & Nabavizadeh, N., Mar 2024, In: Journal of Medical Radiation Sciences. 71, 1, p. 110-113 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ethiodized Oil 100%
  • Radiosurgery 81%
  • Liver 38%
  • Fiducial Markers 26%
  • Radio-Opaque acrylic resin 13%

• Long-term outcomes after amputation and sentinel node biopsy for subungual melanoma: A single-institution series

  Valenzuela, C. D., Fowler, G., Kozuma, K., Kusaka, S. & Vetto, J. T., 2024, (Accepted/In press) In: American journal of surgery.

  Research output: Contribution to journal › Article › peer-review

• Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia

  Pino, J. C., Posso, C., Joshi, S. K., Nestor, M., Moon, J., Hansen, J. R., Hutchinson-Bunch, C., Gritsenko, M. A., Weitz, K. K., Watanabe-Smith, K., Long, N., McDermott, J. E., Druker, B. J., Liu, T., Tyner, J. W., Agarwal, A., Traer, E., Piehowski, P. D., Tognon, C. E., Rodland, K. D., & 1 othersGosline, S. J. C., Jan 16 2024, In: Cell Reports Medicine. 5, 1, 101359.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Proteogenomics 100%
  • Acute Myeloid Leukemia 57%
  • Drug 31%
  • Pharmaceutical Preparations 24%
  • quizartinib 22%

• Masseteric Nerve Transfer for Facial Paralysis Secondary to Parotid Malignancy: A Retrospective Case Series

  Valencia-Sanchez, B. A., Li, R. J., Wax, M. K., Ng, J., Andersen, P. E. & Loyo, M., Apr 1 2024, In: Facial Plastic Surgery and Aesthetic Medicine. 26, 2, p. 103-109 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Nerve Transfer 100%
  • Mandibular Nerve 91%
  • Facial Paralysis 80%
  • Facial Nerve 32%
  • Neoplasms 22%
  2 Scopus citations

• Mass Spectrometry–Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine

  Joshi, S. K., Piehowski, P., Liu, T., Gosline, S. J. C., McDermott, J. E., Druker, B. J., Traer, E., Tyner, J. W., Agarwal, A., Tognon, C. E. & Rodland, K. D., Jan 23 2024, In: Annual Review of Pharmacology and Toxicology. 64, p. 455-479 25 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Proteogenomics 100%
  • Precision Medicine 64%
  • Mutation 50%
  • Dimension 22%
  • Neoplasm Genes 16%

• Medical Management of Inflammatory Bowel Disease

  Rahman, S., Patel, R. K., Boden, E. & Tsikitis, V. L., 2024, (Accepted/In press) In: Surgical Clinics of North America.

  Research output: Contribution to journal › Review article › peer-review

• Microvascular Free Flap Outcomes in Maxillectomy Defects from Invasive Fungal Sinusitis

  Rao, S. M., Knott, P. D., Sweeny, L., Domack, A., Tang, A., Patel, R., Pittman, A. L., Gardner, J. R., Moreno, M. A., Sunde, J., Cave, T. B., Knight, N. D., Greene, B., Pipkorn, P., Joshi, A. S., Thakkar, P., Ji, K., Yang, S., Chang, B. A., Wax, M. K., & 1 othersThomas, C. M., Apr 2024, In: Laryngoscope. 134, 4, p. 1642-1647 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Free Tissue Flaps 100%
  • Sinusitis 98%
  • Debridement 59%
  • Wound Healing 51%
  • Immunocompromised Host 20%

• Microvascular reconstruction of medication related osteonecrosis of the head and neck

  Sweeny, L., Long, S. M., Pipkorn, P., Wax, M. K., Thomas, C. M., Curry, J. M., Yang, S., Lander, D., Chowdhury, F., Amin, D., Kane, A. C., Miles, B. A., Salama, A., Cannady, S. B., Tasche, K., Mann, D. & Jackson, R., 2024, (Accepted/In press) In: Head and Neck.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Osteonecrosis 100%
  • Free Tissue Flaps 98%
  • Neck 65%
  • Head 63%
  • Jaw 44%

• NETosis Is Induced by Complement Component 5a: Implications in the Pathogenesis of Pyoderma Gangrenosum

  Wang, Z., Hornick, N., Vague, M., Yang, D., Keller, J., Kody, S., Leachman, S., Ortega-Loayza, A. G. & Liu, Y., Jan 2024, In: Journal of Investigative Dermatology. 144, 1, p. 184-188.e2

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium

  Verma, A., Chi, Y. Y., Malvar, J., Lamble, A., Chaudhury, S., Agarwal, A., Li, H. T., Liang, G., Leong, R., Brown, P. A., Kaplan, J., Schafer, E. S., Slone, T., Pauly, M., Chang, B. H., Stieglitz, E., Wayne, A. S., Hijiya, N. & Bhojwani, D., Feb 2024, In: Cancers. 16, 3, 496.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private Partnerships

  Herbst, R. S., Blanke, C. D. & Sigal, E. V., Jan 10 2024, In: Clinical Cancer Research. 30, 1, p. 29-32 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Public-Private Sector Partnerships 100%
  • Lung Neoplasms 52%
  • Non-Small Cell Lung Carcinoma 39%
  • United States Food and Drug Administration 21%
  • Clinical Studies 15%

• Novel Biomarkers and Molecular Targets in ALL

  De Sa, H. & Leonard, J., Feb 2024, In: Current Hematologic Malignancy Reports. 19, 1, p. 18-34 17 p.

  Research output: Contribution to journal › Review article › peer-review

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
  • Biomarkers 66%
  • Therapeutics 16%
  • Gene Fusion 16%
  • High-Throughput Nucleotide Sequencing 13%